RecallDepth
Class II Terminated

Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1

Company
Taro Pharmaceuticals U.S.A., Inc.
Recall Initiated
January 8, 2021
Posted
February 10, 2021
Recall Number
D-0246-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
44,256 bottles
Firm Location
Hawthorne, NY, United States

Reason for Recall

CGMP deviations.

Distribution

Nationwide

Lot / Code Info

AC05096, AC05098, and AC05099; Exp 10/31/2022

More recalls by Taro Pharmaceuticals U.S.A., Inc.

View all recalls by this company →

Other recent Class II Drug recalls